Robotic vs. endoscopic: which biopsy method is more accurate for breast cancer?

NCT ID NCT07741734

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study looks back at medical records of 150 women with breast cancer to compare two minimally invasive ways of checking whether cancer has spread to lymph nodes under the arm: robotic-assisted and endoscopic-assisted sentinel lymph node biopsy. The goal is to see which method finds the sentinel node more accurately, has fewer false negatives, and is safer in terms of complications, pain, arm function, and quality of life. It also tracks long-term outcomes like cancer recurrence and survival. The findings could help guide which technique is better for staging breast cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Robotic-assisted sentinel lymph node biopsy compared with endoscopic-assisted sentinel lymph node biopsy
What this could lead to
If robotic-assisted biopsy proves more accurate and safer, it could become a preferred minimally invasive option for staging breast cancer, potentially improving recovery and outcomes.
What could go wrong
This is a retrospective observational study, so it can only show associations, not prove cause and effect. Results may be influenced by patient selection and missing data, and the two techniques may turn out to be equally effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Guangzhou Women and Children's Medical Center, Guangzhou Medical University

    Guangzhou, Guangdong, 510000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.